Background The spread of SP resistance may compromise the effectiveness of intermittent
preventive treatment of malaria in pregnancy (MiP) with sulfadoxine–pyrimethamine (IPTp …

Malaria during pregnancy is a major public health concern and an important contributor to
maternal and infant morbidity and mortality in malaria-endemic countries. 1 Pregnant …

In areas where multidrug-resistant Plasmodium falciparum (MDR-Pf) is prevalent, only
quinine is known to be safe and effective in pregnant women. On the western border of …

Background The emergence of artemisinin resistance in Southeast Asia and Plasmodium
falciparum kelch13 propeller gene mutations in sub-Saharan African pose the greatest …

Malaria is a particular problem in pregnancy because of enhanced sensitivity, the possibility
of placental malaria, and adverse effects on pregnancy outcome. Artemisinin‐containing …

Abstract Background In Papua, Indonesia, maternal malaria is prevalent, multidrug resistant
and associated with adverse outcomes for mother and baby. In March 2006, anti-malarial …

Malaria in pregnancy is a substantial public health issue in many tropical countries.
However, its prevention and treatment have been hindered because of fears of adverse drug …

Background Malaria contributes to maternal illness and anaemia in pregnancy, especially in
first-time mothers, and could harm the mother and the baby. Interventions to prevent or …

Abstract CARMONA-FONSECA, Jaime; AGUDELO-GARCIA, Olga María and ARANGO-
FLOREZ, Eliana. Therapeutic efficacy and adverse events of treatments for vivax and …

Artemether–lumefantrine is a fixed-dose combination containing 20 mg artemether/120 mg
lumefantrine per tablet, used for treating uncomplicated malaria in patients weighing≥ 5 kg …